Muscle biopsy is an essential test for assessing patients with suspected myopathies. It provides valuable information about muscle fiber morphology, pathology distribution, and can help distinguish between neurogenic and myopathic processes. Key diagnostic features on biopsy can confirm or clarify the clinical diagnosis. Proper biopsy technique and handling of the sample are important for optimal histological and molecular analysis.
Introduction to the histology and pathology of the nervous system. Brief overview of most common brain cancers and histological changes of neurons and glial cells
This is not a original work of mine based on Various text books, Journals and also Power Point presentations too
This is a WHO Classification 2021 Update and with brief about all tumor types.also added are the changes that are made in this classification
helpful for Neurology and Neurosurgery Residents
This Power Point Presentation is useful to revise the final exam
The fifth edition of the WHO Classification of Tumors of the Central Nervous System (WHO CNS5) incorporates numerous molecular changes with clinicopathologic utility that are important for the most accurate classification of CNS neoplasms.
WHO CNS5 does not recommend specific methods for molecular assessment.
WHO CNS5 has grouped tumors according to the genetic changes that enable a complete diagnosis.
IDH (Astrocytoma, Oligodendroglioma and Glioblastoma) and H3 (Diffuse midline glioma, Diffuse hemispheric glioma).
Some by looser oncogenic associations. Like MAPK pathway alteration (Multinodular and Vacuolating Neuronal Tumor).
Some are classified by histological similarities even though molecular signatures vary.
Atypical teratoid/rhabdoid tumor, Ganglioglioma, Papillary glioneuronal tumor.
Many by using molecular features to define new types and subtypes.
Medulloblastoma.
The term “type" is used instead of “entity” and “subtype” is used instead of “variant".
The fifth edition of the WHO Classification of Tumors of the Central Nervous System follows the recommendations of the 2019 cIMPACT-NOW Utrecht meeting.
Names have been simplified, and only location, age, or genetic modifiers with clinical utility have been used.
Extra-ventricular neurocytoma vs Central neurocytoma.
The characteristics of tumors that are highly characteristic are included in tumor definitions and descriptions, even if they do not appear in the tumor name itself.
chordoid gliomas occurring in the third ventricle
Sometimes tumor names reflect morphologic features that are not present in every example, and they may also reflect historical associations.
Some myxopapillary ependymomas are minimally myxoid, and some may not be overtly papillary.
Xanthomatous change may be limited to a small fraction of cells in pleomorphic xanthoastrocytomas.
Medulloblast has not been identified in developmental studies, in cases of Medulloblastoma.
As they would be disruptive to clinicians and may lead to confusion, they were not changed.
Tumors are now graded within types, modifier terms like "anaplastic" are not routinely used.
muscle biopsy site indications staining processing of muscle biopsy.pptxDrDivitasaxena1
Muscle biopsy is indicated for general conditions and specific conditions
General ones include weakness of uncertain cause-generalized, proximal, floppy infant syndrome , in case of persistently increased muscle enzymes or in case of muscle pain cramps and stiffness
Specific reasons include hereditary muscle disease connective tissue diseases metabolic diseases drug induced myopathy
Introduction to the histology and pathology of the nervous system. Brief overview of most common brain cancers and histological changes of neurons and glial cells
This is not a original work of mine based on Various text books, Journals and also Power Point presentations too
This is a WHO Classification 2021 Update and with brief about all tumor types.also added are the changes that are made in this classification
helpful for Neurology and Neurosurgery Residents
This Power Point Presentation is useful to revise the final exam
The fifth edition of the WHO Classification of Tumors of the Central Nervous System (WHO CNS5) incorporates numerous molecular changes with clinicopathologic utility that are important for the most accurate classification of CNS neoplasms.
WHO CNS5 does not recommend specific methods for molecular assessment.
WHO CNS5 has grouped tumors according to the genetic changes that enable a complete diagnosis.
IDH (Astrocytoma, Oligodendroglioma and Glioblastoma) and H3 (Diffuse midline glioma, Diffuse hemispheric glioma).
Some by looser oncogenic associations. Like MAPK pathway alteration (Multinodular and Vacuolating Neuronal Tumor).
Some are classified by histological similarities even though molecular signatures vary.
Atypical teratoid/rhabdoid tumor, Ganglioglioma, Papillary glioneuronal tumor.
Many by using molecular features to define new types and subtypes.
Medulloblastoma.
The term “type" is used instead of “entity” and “subtype” is used instead of “variant".
The fifth edition of the WHO Classification of Tumors of the Central Nervous System follows the recommendations of the 2019 cIMPACT-NOW Utrecht meeting.
Names have been simplified, and only location, age, or genetic modifiers with clinical utility have been used.
Extra-ventricular neurocytoma vs Central neurocytoma.
The characteristics of tumors that are highly characteristic are included in tumor definitions and descriptions, even if they do not appear in the tumor name itself.
chordoid gliomas occurring in the third ventricle
Sometimes tumor names reflect morphologic features that are not present in every example, and they may also reflect historical associations.
Some myxopapillary ependymomas are minimally myxoid, and some may not be overtly papillary.
Xanthomatous change may be limited to a small fraction of cells in pleomorphic xanthoastrocytomas.
Medulloblast has not been identified in developmental studies, in cases of Medulloblastoma.
As they would be disruptive to clinicians and may lead to confusion, they were not changed.
Tumors are now graded within types, modifier terms like "anaplastic" are not routinely used.
muscle biopsy site indications staining processing of muscle biopsy.pptxDrDivitasaxena1
Muscle biopsy is indicated for general conditions and specific conditions
General ones include weakness of uncertain cause-generalized, proximal, floppy infant syndrome , in case of persistently increased muscle enzymes or in case of muscle pain cramps and stiffness
Specific reasons include hereditary muscle disease connective tissue diseases metabolic diseases drug induced myopathy
Myopathies - In detail (Classification and images) Dr. Tushar Kariya
In this presentation I've tried to cover myopathies, its classification and related images with H&E and special stain wherever its possible. Hope it helps you guys to understand the entity better.
A neuromuscular disorder that leads to weakness of skeletal muscles.
Symptoms
Causes
Prevention
Complications
Common tests & procedures
Neurological examination:
Repetitive nerve stimulation test:
Antibody test:
Pulmonary function tests (PFTs): To check any breathing difficulty.
CT scan: To rule out a presence of tumor in thymus.
Magnetic resonance imaging (MRI): MRI of the chest is performed to rule out a presence of tumor in thymus.
Edrophonium (Tensilon) test:
Medication
Procedures
Nutrition
CONCEPT OF NODOPATHIES AND PARANODOPATHIES.pptxNeurologyKota
emergence of autoimmune neuropathies and role of nodal and paranodal regions in their pathophysiology.
Peripheral neuropathies are traditionally categorized into demyelinating or axonal.
dysfunction at nodal/paranodal region key for better understanding of patients with immune mediated neuropathies.
antibodies targeting node and paranode of myelinated nerves have been increasingly detected in patients with immune mediated neuropathies.
have clinical phenotype similar common inflammatory neuropathies like Guillain Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy
they respond poorly to conventional first line immunotherapies like IVIG
This presentation briefs out the approach of dementia assessment in line with consideration of recent advances. Now the pattern of assessment has evolved towards examining each individual domain rather than lobar assessment.
This presentation contains information about Dementia in Young onset. Also it describes the etiologies, clinical feature of common YOD & their management.
Entrapment Syndromes of Lower Limb.pptxNeurologyKota
This presentation contains information about the various Entrapment syndromes of Lower limb in descending order of topography. It also contains information about etiology, clinical features and management of each of these entrapment syndromes with special emphasis on electrodiagnostic confirmation.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
2. it is an essential element in the assessment of a
patient with suspected myopathy.
The history 1860 when Duchenne first performed a
biopsy on a patient with symptoms of myopathy.
time for biopsy, muscle to select, how many specimens
to obtain, and how to handle the specimen are
individualized
5. Specific reasons:
Hereditary muscle disease in other family members - Carrier detection
metabolic diseases such as storage disease
Suspicion of steroid myopathy in treated myositis - Exclude drug induced
myopathy
Conflicting clinical ,EMG or lab findings
to distinguish between myopathy and neuropathy.
Confirm/reinforce clinical diagnosis
6. A normal biopsy in pt with high level of clinical suspicion of
a myopathy
patient with known inflammatory myopathy who, after
improvement with steroid therapy, develops increasing
weakness.
Biopsy findings can help distinguish between recurrence of
the inflammatory disorder and steroid myopathy.
8. • Muscle with moderate disease, NOT severe
• Muscle belly, not from tendon
• Proximal myopathies/generalised systemic disease- Vastus
Lateralis
• Other sites-Biceps,gatronemius
• Avoid Deltoid,muscle that are site of EMG,injections/trauma
• Imaging used to select pathological muscle site in difficult cases.
10. Sample size: 0.5 cm diameter
1cm length
Biopsy is processed:
1.Paraffin embedding
2.Histochemistry
3.For electron microscopy
4.For molecular biology
11. The sample can be sent to the laboratory on saline gauze in a
sealed container on ice
should not be immersed
Ideally, immediately transported to the laboratory for
processing
Fixed in paraformaldehyde, 3% glutaraldehyde, 10% formalin
12. Fresh Fixed
Muscle may be saved in saline moistened guage for several hrs
Keep the specimen cool
Do NOT immerse in saline ,fixative or other liquid
Glutaraldehyde, 4degree
EM ( 1mm x 0.5 cm)
Formalin
PARAFFIN (0.5x0.5cm)
inflammatory myopathies, vasculitis
Snap freeze
HISTOCHEMISTRY
(0.5x0.5cm) stains
Gel electrophoresis
western blot
13. trauma to the muscle- disrupts architecture
Electrocautery should not be used
sample coagulated by the application
of electrocautery
contraction band artifact
19. H & E
Used to evaluate gen architecture of muscle and
variation in morphology of individual fibres
•Variation in fascicular architecture
•Variation in fiber size
•Necrosis and degeneration of muscle fibres
•Nuclear characteristics
•Type & distribution of inflammatory infiltrate
•Interstitial changes
24. Duchene muscular dystrophy
A hyalinised fiber is a fiber which has lost its cross
striations, has homogenous pale
Cytoplasm, Usually these fibers are rounded.
26. pale stained on H&E and infiltrated by phagocytes
(myophagocytosis) - DMD
Fiber necrosis Perifascicular necrosis
27. Pathologic features Disease
Small groups of necrotic
fibres
DMD
Perifascicular necrosis Dermatomyositis
Random fibre necrosis PM,IBM
Extensive,diffuse Rhabdomyolysis
34. Type 1 fiber
hypertrophy
Type 2 fiber
hypertrophy
Type 1&2 fiber
hypertrophy
ISMA
Normal Atheletes
Sprinters Limb girdle
dystrophy,IBM,myotonia
congenita,acromegaly
Normal Hypertrophy
36. recognition of split fibers
is by a thin fibrous
septum, often
associated with a
nucleus that crosses
partway but not all the
way across the fiber.
38. PH 9.4 - type 1 fibers - pale ,
type 2 fibers – dark,
viceversa at 4.6
Type predominance – if > 55% (1, 2A,2B),
>80% - type 2
39.
40. Type 1 - normal in the gastrocnemius and deltoid muscles,
hallmark of congenital myopathies and many of the
early dystrophies.
Type 2 - lateral head of the quadriceps muscle,
jSMA, MND
41. Type 1 fiber atrophy - myotonic dystrophy type 1,
congenital myopathies and dystrophies
Type 2 fiber atrophy - common , non specific –
chronic corticosteroid administration,
disuse,
RA, CTD,
Cancer,
mental retardation,
myasthenia gravis
42. Creatine kinase level: To rule out certain categories of myopathies
because different myopathies tend to generate a different levels of
elevation in CPK.
•High: (e.g. Dystrophinopathies) 200-300 times of normal.
•Intermediate: (e.g. Inflammatory myopathy) 20-30 times of normal.
•Low: (e.g. Neurogenic disorder) 2-5 times of normal.
43. Lab. – Serum CK : elevated 20-100x normal
EMG : myopathic features
Muscle biopsy- Fiber necrosis & regeneration
Variation in fiber size,
internalisation of nuclei
proliferation of endomysial connective tissue.
Deficiency of dystrophin seen on
western blot analysis & IHC staining
DNA analysis : mutation of gene that encodes dystrophin
44. • Lab. – CK : elevated
-EMG : myopathic
- muscle biopsy : similar to DMD
: reduced amount or abnormality of
dystrophin( Dx)
- DNA analysis : deletions or duplications( Dx)
46. • Lab. – Dx ; usually based on clinical findings
-CK : N or mildly elevated
-EMG : evidence of myotonia
-Biopsy : variation in fiber size,
increase in internal
nuclei(chains) ring,
selectively involves type – 1 fiber in 50%
Myotonic dystrophy
47. • Lab.– EMG: myopathic features
-CK : 2-3x N
-BIOPSY : presence of tubular filaments in muscle
cell nuclei,
mild dystrophic changes with nuclear
internalisation ,fiber atrophy,
Interstital fibrosis,
rimmed vacuoles in type 1 fibres
48. • Lab. – CK : N or elevated
- EMG: myopathic pattern
- BIOPSY: Atrophic muscle fibres in
clusters/groups in absence of necrosis,
- Moth eaten fibres and perivascular
inflammatory infiltrate
49. PM DM IBM
Muscle Biopsy “primary”
inflammation with
the CD8/MHC-I
complex & vacuoles
Endomysial
inflammation
Perifascicular,
perimysial, or
perivascular
infiltrates,
perifascicular atrophy
inflammatory
reactions
around blood vessels,
Primary inflammation
with CD8/MHC-I
complex; vacuolated
fibers with
b-amyloid deposits ,
Endomysial
inflammation
50. Perifascicular atrophy
Degeneration
Inflammatory cells in the perimysium
surrounding a blood vessel
51. Congenital myopathies
1.Central core disease
2.Multicore disease
3.Nemaline(Rod) myopathy
4.Centronuclear myopathy
5.Congenital fibre type disproportion
• Lab. - CK: usually N or slightly elevated
- EMG : myopathic, myotonic discharges
- Biopsy : features specific to each type
57. • Are the muscle fibres abnormal??
• Is the pathologic process-
neurogenic/myopathic??
• What is the distribution of pathology??
• Are there any diagnostic features??
58. If abnormal??
Size-small or large
Shape-rounded or angular
Type-grouping, fiber predominance
Internal architecture-disordered/lost, vacuoles,Internal nuclei, inclusions
Storage/acumulated material-glycogen, lipid, mitochondria
NEUROGENIC/MYOGENIC
• Shape of muscle fibers –
• ROUND Myopathic
• ANGULAR Neurogenic
60. UNIFORM- Dystrophy,
REGIONAL - --
Neuropathy -Progressive denervation with reinnervation
Myopathy- Myopathic grouping, perifascicular atrophy
Inflammatory myopathies -Patchy fascicular changes,
focal denervation of Group of muscle fibers
SCATTERED muscle fibers: Acute myopathy, Acute neuropathy
61. In patients with suspected myopathy, needle EMG should be
performed on muscles on only one side of the body; a
subsequent muscle biopsy should be performed on the other
side.
62.
63. Bradley’s Neurology in Clinical Practice, 7th edition, 1915-19
C. Sundaram and Megha S. Uppin (2012). Approach to the
Interpretation of Muscle Biopsy, Muscle Biopsy, Dr. Challa
Sundaram (Ed.), ISBN: 978-953-307-778-9
Emedicine, medscape